A new digital pill system could save billions in health care costs — but will courts take it too far?

Quick Read

Scientists say they are a step closer to growing fully functioning replacement kidneys, after promising results in animals

Quick Read

A genomic entrepreneur plans to sell genetic workups for as little as $250. But $25,000 gets you “a physical on steroids.”

Quick Read

Fourteen years ago, a leading drug maker published a study showing that the antidepressant Paxil was safe and effective for teenagers. On Wednesday, a major medical journal posted a new analysis of the same data concluding that the opposite is true

Quick Read

On a slippery slope? Barron Lerner & Arthur Caplan: The slippery slope is an argument frequently invoked in the world of bioethics. It connotes the notion that a particular course of action will lead inevitably to undesirable and unintended consequences. Saying no to the original action, even if that act is moral in itself, may, in light of the slope that looms, be the ethical thing to do.

Quick Read

The company that began as a source of genealogical data now hopes to marry that information with DNA data—and sell it for research

Quick Read

To realize the full potential of large data sets, researchers must agree on better ways to pass data around, says Martin Bobrow

Quick Read

Health care and its availability are important drivers of public health, but everyone knows behavior is a big deal, too. Over the past 50 years, Americans have quit smoking, started driving safer cars, put on weight, and bought more guns

Quick Read